Adagene Inc.

Adagene Inc. is a biotechnology company focused on the discovery and development of innovative antibody-based therapies. The company's primary function is to harness its proprietary Dynamic Precision Library (DPL) platform to generate novel therapeutic antibodies targeting complex and challenging diseases, particularly in the field of oncology. Adagene's approach is designed to expand the potential for antibody therapeutics, offering solutions for medical conditions that have proven to be difficult to treat with traditional methods. The company is notable for its series of next-generation, safer, and more effective antibody therapies that aim to enhance patient outcomes while minimizing adverse effects. Adagene's commitment to cutting-edge research and collaboration with major pharmaceutical entities underscores its significance in the biotechnology and healthcare industries. By focusing on immune checkpoint pathways and dynamic epitope mapping, Adagene stands as a key player in the advancement of precision medicine, making strides toward impactful healthcare solutions on a global scale.